Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors In Vivo

Anticancer Research

Volumn 31, Issue 11, 2011, Pages 3659-3664

  Suojanen, Juho ^a,b,c,d   Vilen, Suvi Tuuli ^a,b   Nyberg, Pia ^c,d   Heikkilä, Pia ^a,b   Penate Medina, Oula ^e,f   Saris, Per E J ^g   Hagström, Jaana ^b,g   Ranta, Tanja Maria ^g   Salo, Tuula ^c,d   Sorsa, Timo ^a,b   Reunanen, Justus ^g  

^a BIOMEDICUM HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e CTT Cancer Targeting Technologies   (Finland)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Gelatinase; Green fluorescent protein; Matrix metalloproteinases; Peptide; Tongue carcinoma; Xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; DIETHYLENE TRIAMINE PENTAACETIC ACID CYCLO IN 111; DIETHYLENE TRIAMINE PENTAACETIC ACID CYCLO IN 111 GREEN FLUORESCENT PROTEIN; GELATINASE INHIBITOR; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TONGUE CARCINOMA; TUMOR XENOGRAFT;

ANIMALS; CELL PROLIFERATION; ENZYME INHIBITORS; FEMALE; GELATINASES; GREEN FLUORESCENT PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; PEPTIDE FRAGMENTS; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 83055187109     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Friedl P and Wolf K: Tumor-cell invasion and migration: diversity and escape mechanisms. Nature Rev Cancer 3: 362-374, 2003. (Pubitemid 37328856)
2. Curran S and Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 36: 1621-1630, 2000. (Pubitemid 30616366)
3. Vihinen P and Kähäri VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166, 2002 (Pubitemid 34309470)
4. Fischer JF and Mobashery S: Recent advances in MMP inhibitor design. Cancer Metastasis Rev 25: 115-136, 2006.
5. Dezube BJ, Krown SE, Lee JY, Bauer KS and Aboulafia DM: Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an aids malignancy consortium study. J Clin Oncol 24: 1389-1394, 2006. (Pubitemid 46622003)
6. Lara PN, Stadler WM, Longmate J, Quinn DI, Wexler J, Van Loan M, Twardowski P, Gumerlock PH, Vogelzang NJ, Vokes EE, Lenz HJ, Doroshow JH and Gandara DR: A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastasis. Clin Cancer Res 15(5): 1556-1563, 2006.
7. Lopez-Otin C and Matrizian LM: Emerging roles of proteases in tumor suppression. Nature Rev Cancer 7: 800-808, 2007. (Pubitemid 47463671)
8. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E and Pasqualini R: Tumor targeting with a selective gelatinase inhibitor. Nat Biotechol 17: 768-774, 1999. (Pubitemid 29365104)
9. Penate-Medina OP, Kairemo K, Valtanen H, Kangasniemi A, Kaukinen S, Ahonen I, Permi P, Annila A, Sneck M, Holopainen JM, Karonen SL, Kinnunen PK and Koivunen E: Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide. Anticancer Res 25(1A): 33-42, 2005. (Pubitemid 40470088)
10. Björklund M, Heikkilä P and Koivunen E: Peptide inhibition of catalytic and noncatalytic activities of matrix metal loproteinase-9 blocks tumor cell migration and invasion. J Biol Chem 279: 29589-29597, 2004. (Pubitemid 38915841)
11. Heikkilä P, Suojanen J, Pirila E, Väänänen A, Koivunen E, Sorsa T and Salo T: Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides. Int J Cancer 118: 2202-2209, 2006.
12. Kolonin MG, Sun J, Do KA, Vidal CI, Ji Y, Baggerly KA, Pasqualini R and Arap W: Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 20: 979-981, 2006.
13. Reunanen J, Ranta TM, Penate-Medina O, Suojanen J, Sorsa T, Salo T, Koivunen E and Saris PE: A chimera of green fluorescent protein with gelatinase-binding and tumor-targeting peptide. Prot Expr Purif 72: 234-237, 2010.
14. Suojanen J, Sorsa T and Salo T: Tranexamic acid can inhibit tongue squamous cell carcinoma invasion in vitro. Oral Dis 15: 170-175, 2009.
15. Suojanen J, Salo T, Koivunen E, Sorsa T and Pirilä E: A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth. Cancer Biol Ther 8: 2362-2370, 2009.
16. Pirilä E, Sharabi A, Salo T, Quaranta V, Tu H, Heljasvaara R, Koshikawa N, Sorsa T and Maisi P: Matrix metalloproteinase process the laminin-5 γ2-chain and regulate epithelial cell migration. Biochem Biophys Res Comm 303: 1012-1107, 2003.
17. Nurmenniemi S, Sinikumpu T, Alahuhta I, Salo S, Sutinen M, Santala M, Risteli J, Nyberg P and Salo T: A novel organotypic model mimics the tumor microenvironment. Am J Pathol 175(3): 1281-1291, 2009.
18. Caggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature Cell Biol 9: 1392-1400, 2007. (Pubitemid 350201752)
19. Risteli J, Elomaa I, Niemi S, Novamo A and Risteli L: Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39: 635-640, 1993. (Pubitemid 23118314)
20. Suojanen J, Salo T, Sorsa T and Koivunen E: AlphaMbeta2 integrin modulator exerts antitumor activity in vivo. Anticancer Res 27: 3775-3781, 2007.
21. Laaksonen M, Suojanen J, Nurmenniemi S, Läärä E, Sorsa T and Salo T: The enamel matrix derivative (Emdogain) enhances human tongue carcinoma cells gelatinase production, migration and metastasis formation. Oral Oncol 44: 733-742, 2008. (Pubitemid 351992918)
22. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol 2: 737-744, 2000.
23. Ahn GO and Brown JM: Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13: 193-205, 2008.
24. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P and Garner HA: Elevated matrix metalloproteinase and angiostatin levels in alfa 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 97: 2202-2207, 2000. (Pubitemid 30134046)
25. Bendrik C, Robertson J, Gauldie J and Dabrosin C: Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res 68(9): 3405-3412, 2008.
26. Ito H, Hatori M, Kinugasa Y, Irie T, Tachikawa T and Nagumo M: Comparison of the expression profile of metastasis-associated genes between primary and circulating cancer cells in oral squamous cell carcinoma. Anticancer Res 23: 1425-1432, 2003.
27. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G and Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts; purification and activation of the precursor and enzymatic properties. Eur J Biochem 194: 721-730, 1990.
28. Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T and Seiki M: Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO 20(17): 4782-4793, 2001. (Pubitemid 32848631)
29. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y and Seiki M: TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273(26):16098-16103, 1998. (Pubitemid 28311379)
30. Arap W, Kolonin M, Trepel M, Lahdenranta J, Cardó-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ and Pasqualini R: Steps toward mapping the human vasculature by phage display. Nature Med 8(2): 121-127, 2002. (Pubitemid 34155122)
31. Järvinen TA and Ruoslahti E: Target-seeking antifbrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci USA 107: 21671-21676, 2010.